Toshiyuki Iwahata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Toshiyuki Iwahata has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Akiyoshi Osaka
International Center of Reproductive Medicine, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan
4 shared publications - Hiroshi Okada
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan
3 shared publications - Kazutaka Saito
Department of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya 343-8555, Japan
3 shared publications - Kouhei Sugimoto
International Center of Reproductive Medicine, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, Japan
3 shared publications Akinori Nakayama
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Saitama Japan
2 shared publications- Hiroki Tsujioka
Department of Urology Dokkyo Medical University Saitama Medical Center Koshigaya Japan
2 shared publications
Latest Publications
- Open Access
- 3 February 2026
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 98 (1) , 14612
Varicocelectomy for nonobstructive azoospermia should be considered only in carefully selected patients: opinions based on treatment experience at Dokkyo Medical University
Introduction: The need for varicocelectomy for varicoceles complicated by nonobstructive azoospermia (NOA) has long been debated in the field of male infertility. In this study, we analyzed the clinical outcomes of varicocelectomies for varicoceles in patients with NOA.Methods: We retrospectively reviewed the following data of 11 patients with NOA and varicoceles who underwent varicocelectomies: age at admission, right and left testicular volumes, operative varicocele grades, operative site, body mass index, endocrine and genetic examination results, number of semen analyses before and after varicocelectomy, sperm appearance rate in ejaculated semen after varicocelectomy, sperm retrieval rate (SRR) with microdissection testicular sperm extraction (MD-TESE), and histopathological analysis results of testicular tissue.Results: Varicocelectomies were performed bilaterally and on the left side in 1 and 10 patients, respectively. The number of pre- and postoperative semen analyses was 1-3 and 1-7, respectively. Ejaculated semen analysis after varicocelectomy did not reveal sperm in any patient. Ten patients underwent MD-TESE; however, sperm was retrieved from only two patients (20%). Pathological examination of seminiferous tubular tissue collected by MD-TESE revealed hyalinization in one patient, Sertoli cells in eight, and hypospermatogenesis in two.Conclusions: Sperm could not be retrieved from the ejaculated semen of patients with NOA and varicoceles who underwent varicocelectomies, and the SRR of MD-TESE was suboptimal. These results suggest that varicocelectomy should be performed cautiously in patients with NOA.
- 3 February 2026
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 98 (1) , 14612
Open AccessVaricocelectomy for nonobstructive azoospermia should be considered only in carefully selected patients: opinions based on treatment experience at Dokkyo Medical University
Introduction: The need for varicocelectomy for varicoceles complicated by nonobstructive azoospermia (NOA) has long been debated in the field of male infertility. In this study, we analyzed the clinical outcomes of varicocelectomies for varicoceles in patients with NOA.Methods: We retrospectively reviewed the following data of 11 patients with NOA and varicoceles who underwent varicocelectomies: age at admission, right and left testicular volumes, operative varicocele grades, operative site, body mass index, endocrine and genetic examination results, number of semen analyses before and after varicocelectomy, sperm appearance rate in ejaculated semen after varicocelectomy, sperm retrieval rate (SRR) with microdissection testicular sperm extraction (MD-TESE), and histopathological analysis results of testicular tissue.Results: Varicocelectomies were performed bilaterally and on the left side in 1 and 10 patients, respectively. The number of pre- and postoperative semen analyses was 1-3 and 1-7, respectively. Ejaculated semen analysis after varicocelectomy did not reveal sperm in any patient. Ten patients underwent MD-TESE; however, sperm was retrieved from only two patients (20%). Pathological examination of seminiferous tubular tissue collected by MD-TESE revealed hyalinization in one patient, Sertoli cells in eight, and hypospermatogenesis in two.Conclusions: Sperm could not be retrieved from the ejaculated semen of patients with NOA and varicoceles who underwent varicocelectomies, and the SRR of MD-TESE was suboptimal. These results suggest that varicocelectomy should be performed cautiously in patients with NOA.
- Open Access
- 1 January 2025
- Published by Bioscientifica in Reproduction and Fertility
- Vol. 6 (1)
Serum FSH levels can predict sperm identification in semen once diagnosed azoospermia
Graphical Multiple semen analyses are important for identifying patients with severe oligozoospermia (SOS) or cryptozoospermia (CZO). Moreover, clinical predictive factors for CZO and SOS are warranted. Therefore, we aimed to identify predictors of sperm retrieval in patients with a prior diagnosis of nonobstructive azoospermia (NOA) based on repeat semen analysis. We retrospectively included 209 patients diagnosed with NOA. Data regarding age at diagnosis, body mass index, testicular volume, serum luteinizing hormone, follicle-stimulating hormone (FSH) and testosterone levels, smoking history and testicular microlithiasis were analyzed. Patients were classified into the falsely reported azoospermia (FAZO) and true azoospermia (TAZO) groups. Furthermore, FAZO-related factors were evaluated using the Mann–Whitney U test and univariate and multivariate analysis logistic regression models. Regarding FAZO-related factors, the cut-off level was determined using receiver operating characteristic (ROC) curve analysis. Among 209 patients with NOA, 33 (15.8%) had spermatozoa identified in subsequent semen analyses. Multivariate analysis revealed that the FAZO group had significantly lower FSH levels than the TAZO group. ROC curve analysis showed that the cut-off value for the FSH level was 15.3 mIU/mL, with 26 (78.8%) and 29 (16.5%) patients in the FAZO and TAZO groups, respectively, having FSH levels ≤15.3 mIU/mL. In conclusion, the FSH level was a predictive factor for FAZO. In patients diagnosed with azoospermia who have relatively low FSH levels, multiple semen analyses might facilitate identification of sperm in ejaculated semen. Lay summary: We evaluated 209 patients diagnosed with spermless semen at prior medical institutions. After thorough semen analyses at our hospital, sperm were identified in the ejaculates of 33 (15.8%) patients. We performed comparisons between patients with and without identified sperm. The serum FSH level was identified as a significant predictive factor for sperm presence. FSH stimulates testicular growth and function and promotes sperm development. Patients who had relatively low and high FSH levels for patients with spermless semen had an increased and decreased chance, respectively, of having sperm identified in ejaculated semen through repeat thorough semen analyses. Sperm might be identified in ejaculates of patients diagnosed with spermless semen who have relatively low FSH levels.
- 1 January 2025
- Published by Bioscientifica in Reproduction and Fertility
- Vol. 6 (1)
Open AccessSerum FSH levels can predict sperm identification in semen once diagnosed azoospermia
Graphical Multiple semen analyses are important for identifying patients with severe oligozoospermia (SOS) or cryptozoospermia (CZO). Moreover, clinical predictive factors for CZO and SOS are warranted. Therefore, we aimed to identify predictors of sperm retrieval in patients with a prior diagnosis of nonobstructive azoospermia (NOA) based on repeat semen analysis. We retrospectively included 209 patients diagnosed with NOA. Data regarding age at diagnosis, body mass index, testicular volume, serum luteinizing hormone, follicle-stimulating hormone (FSH) and testosterone levels, smoking history and testicular microlithiasis were analyzed. Patients were classified into the falsely reported azoospermia (FAZO) and true azoospermia (TAZO) groups. Furthermore, FAZO-related factors were evaluated using the Mann–Whitney U test and univariate and multivariate analysis logistic regression models. Regarding FAZO-related factors, the cut-off level was determined using receiver operating characteristic (ROC) curve analysis. Among 209 patients with NOA, 33 (15.8%) had spermatozoa identified in subsequent semen analyses. Multivariate analysis revealed that the FAZO group had significantly lower FSH levels than the TAZO group. ROC curve analysis showed that the cut-off value for the FSH level was 15.3 mIU/mL, with 26 (78.8%) and 29 (16.5%) patients in the FAZO and TAZO groups, respectively, having FSH levels ≤15.3 mIU/mL. In conclusion, the FSH level was a predictive factor for FAZO. In patients diagnosed with azoospermia who have relatively low FSH levels, multiple semen analyses might facilitate identification of sperm in ejaculated semen. Lay summary: We evaluated 209 patients diagnosed with spermless semen at prior medical institutions. After thorough semen analyses at our hospital, sperm were identified in the ejaculates of 33 (15.8%) patients. We performed comparisons between patients with and without identified sperm. The serum FSH level was identified as a significant predictive factor for sperm presence. FSH stimulates testicular growth and function and promotes sperm development. Patients who had relatively low and high FSH levels for patients with spermless semen had an increased and decreased chance, respectively, of having sperm identified in ejaculated semen through repeat thorough semen analyses. Sperm might be identified in ejaculates of patients diagnosed with spermless semen who have relatively low FSH levels.
- Open Access
- 31 July 2024
- Published by Wiley in IJU Case Reports
- Vol. 7 (5) , 364-367
Testicular seminoma in transverse testicular ectopia
Introduction: Transverse testicular ectopia is a rare anomaly in which both testes descend toward the same side of the hemiscrotum.Case presentation: A 35‐year‐old man presented with right inguinal enlargement. Computed tomography showed a normal testis in the right hemiscrotum and a 58 mm heterogeneous mass in the right inguinal area. No testis was observed in the left hemiscrotum. The vascular structures extended from the right inguinal mass to the left renal vein. Consequently, the left testicular tumor was diagnosed as transverse testicular ectopia, and a left orchiectomy was performed. The histological diagnosis was seminoma stage pT2. Furthermore, left para‐aortic lymph node metastasis developed 10 months postoperatively. A complete response was obtained after systemic chemotherapy.Conclusion: Awareness of seminomas in transverse testicular ectopia could facilitate appropriate diagnosis and treatment. Furthermore, the location of the lymph node metastasis indicated that the ectopic testis could have originated from the left side.
- 31 July 2024
- Published by Wiley in IJU Case Reports
- Vol. 7 (5) , 364-367
Open AccessTesticular seminoma in transverse testicular ectopia
Introduction: Transverse testicular ectopia is a rare anomaly in which both testes descend toward the same side of the hemiscrotum.Case presentation: A 35‐year‐old man presented with right inguinal enlargement. Computed tomography showed a normal testis in the right hemiscrotum and a 58 mm heterogeneous mass in the right inguinal area. No testis was observed in the left hemiscrotum. The vascular structures extended from the right inguinal mass to the left renal vein. Consequently, the left testicular tumor was diagnosed as transverse testicular ectopia, and a left orchiectomy was performed. The histological diagnosis was seminoma stage pT2. Furthermore, left para‐aortic lymph node metastasis developed 10 months postoperatively. A complete response was obtained after systemic chemotherapy.Conclusion: Awareness of seminomas in transverse testicular ectopia could facilitate appropriate diagnosis and treatment. Furthermore, the location of the lymph node metastasis indicated that the ectopic testis could have originated from the left side.
- Open Access
- 8 November 2022
- Published by Wiley in IJU Case Reports
- Vol. 6 (2) , 97-100
A regressed germ cell tumor discovered secondary to azoospermia
Introduction: Regressed germ cell tumors are a rare disease commonly diagnosed with metastatic symptoms without local symptoms in the testis.Case presentation: A 33‐year‐old man with azoospermia was referred to our hospital. His right testis was slightly swollen, and ultrasonography revealed hypoechogenicity of the right testis with decreased blood flow. Right high orchiectomy was performed. Pathologically, the seminiferous tubules were absent or highly atrophied with vitrification degeneration; however, no neoplastic lesion was confirmed. One‐month post‐surgery, the patient noticed a mass in the left supraclavicular fossa, of which a biopsy revealed seminoma. The patient was diagnosed with a regressed germ cell tumor and underwent systemic chemotherapy.Conclusion: We reported the first case of a regressed germ cell tumor discovered due to complaints of azoospermia.
- 8 November 2022
- Published by Wiley in IJU Case Reports
- Vol. 6 (2) , 97-100
Open AccessA regressed germ cell tumor discovered secondary to azoospermia
Introduction: Regressed germ cell tumors are a rare disease commonly diagnosed with metastatic symptoms without local symptoms in the testis.Case presentation: A 33‐year‐old man with azoospermia was referred to our hospital. His right testis was slightly swollen, and ultrasonography revealed hypoechogenicity of the right testis with decreased blood flow. Right high orchiectomy was performed. Pathologically, the seminiferous tubules were absent or highly atrophied with vitrification degeneration; however, no neoplastic lesion was confirmed. One‐month post‐surgery, the patient noticed a mass in the left supraclavicular fossa, of which a biopsy revealed seminoma. The patient was diagnosed with a regressed germ cell tumor and underwent systemic chemotherapy.Conclusion: We reported the first case of a regressed germ cell tumor discovered due to complaints of azoospermia.
- 30 April 2021
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 13 (4) , 435-439
Does mirabegron deteriorate spermatogenesis? A lesson from spinal cord injury cases
Objectives: To evaluate whether the long‐term usage of mirabegron, which was reported to have potential side effects on male reproductive organs in animal studies, was harmful to spermatogenesis in human testis.Methods: Thirty consecutive patients with spinal cord injury (20‐48 years old) who performed clean intermittent catheterization were involved in this study. Ten patients were treated with mirabegron (50 mg/d) for more than 2 years and refrained from using an antimuscarinic agent due to the side effects of constipation and dry mouth. Twenty patients were treated with neither anticholinergic agents nor mirabegron. All underwent conventional testicular sperm extraction. The sperm recovery rate and histopathologic findings of the retrieved testicular tissue were compared between both groups.Results: We found no difference in the sperm recovery rate (P = .083) between both groups. Spinal cord injury patients treated with mirabegron had better spermatogenesis than those not treated with mirabegron (P < .05).Conclusions: From these data, we conclude that the therapeutic dose of mirabegron had no harmful effect on spermatogenesis in spinal cord injury patients of reproductive age.
- 30 April 2021
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 13 (4) , 435-439
Does mirabegron deteriorate spermatogenesis? A lesson from spinal cord injury cases
Objectives: To evaluate whether the long‐term usage of mirabegron, which was reported to have potential side effects on male reproductive organs in animal studies, was harmful to spermatogenesis in human testis.Methods: Thirty consecutive patients with spinal cord injury (20‐48 years old) who performed clean intermittent catheterization were involved in this study. Ten patients were treated with mirabegron (50 mg/d) for more than 2 years and refrained from using an antimuscarinic agent due to the side effects of constipation and dry mouth. Twenty patients were treated with neither anticholinergic agents nor mirabegron. All underwent conventional testicular sperm extraction. The sperm recovery rate and histopathologic findings of the retrieved testicular tissue were compared between both groups.Results: We found no difference in the sperm recovery rate (P = .083) between both groups. Spinal cord injury patients treated with mirabegron had better spermatogenesis than those not treated with mirabegron (P < .05).Conclusions: From these data, we conclude that the therapeutic dose of mirabegron had no harmful effect on spermatogenesis in spinal cord injury patients of reproductive age.
- Open Access
- 4 June 2014
- Published by Taylor & Francis in Systems Biology in Reproductive Medicine
- Vol. 60 (6) , 373-376
Inflammatory bowel disease in subfertile men and the effect of mesalazine on fertility
This study aimed to examine the effect of mesalazine on fertility. In this retrospective analysis of 1,225 male subfertile patients, we reviewed the cases of inflammatory bowel disease (IBD) in the medical records and evaluated the prevalence of the disease in our reproduction center. Specifically, we examined IBD patients who ceased mesalazine during male infertility treatment, and compared the seminogram of these patients before and after discontinuation of mesalazine. We also analyzed pregnancy outcome after discontinuation. The prevalence rate of Crohn's disease and ulcerative colitis in our male infertile patients was 163 per 100,000 men and 490 per 100,000 men, respectively. Seven patients had taken mesalazine and six of them subsequently stopped the medication. The mean values of sperm concentration, sperm motility, percentage of normal formed sperm, semen volume, and total motile sperm count taken before discontinuation increased after discontinuation of mesalazine. Among these parameters, the sperm motility and total motile sperm count were significantly improved (p < 0.05) after discontinuation. Of the six patients who stopped the drug, four achieved pregnancy with their partners, with two of the four men showing significant improvement not only in the percentage of normal shaped sperm but also sperm motility and total motile sperm count. This study provides further insight into the rarely investigated relationship between male fertility and mesalazine.
- 4 June 2014
- Published by Taylor & Francis in Systems Biology in Reproductive Medicine
- Vol. 60 (6) , 373-376
Open AccessInflammatory bowel disease in subfertile men and the effect of mesalazine on fertility
This study aimed to examine the effect of mesalazine on fertility. In this retrospective analysis of 1,225 male subfertile patients, we reviewed the cases of inflammatory bowel disease (IBD) in the medical records and evaluated the prevalence of the disease in our reproduction center. Specifically, we examined IBD patients who ceased mesalazine during male infertility treatment, and compared the seminogram of these patients before and after discontinuation of mesalazine. We also analyzed pregnancy outcome after discontinuation. The prevalence rate of Crohn's disease and ulcerative colitis in our male infertile patients was 163 per 100,000 men and 490 per 100,000 men, respectively. Seven patients had taken mesalazine and six of them subsequently stopped the medication. The mean values of sperm concentration, sperm motility, percentage of normal formed sperm, semen volume, and total motile sperm count taken before discontinuation increased after discontinuation of mesalazine. Among these parameters, the sperm motility and total motile sperm count were significantly improved (p < 0.05) after discontinuation. Of the six patients who stopped the drug, four achieved pregnancy with their partners, with two of the four men showing significant improvement not only in the percentage of normal shaped sperm but also sperm motility and total motile sperm count. This study provides further insight into the rarely investigated relationship between male fertility and mesalazine.